MedTrace Logo

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

NCT00348582 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-06-25

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

Conditions

  • Cataract

Interventions

DRUG

Ketorolac, Nepafenac

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Francis Mah, MD · University Pittsburgh Medical Center Eye and Ear Institute

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348582 on ClinicalTrials.gov